The trajectory of Sildenafil presents a check here complex picture for those considering investment. While the initial launch generated substantial returns, the expiration of its patent opened the floodgates to off-brand competitors, dramatically reducing market share. This poses a unique challenge for drug manufacturers banking on comparable block
Sildenafil and Pharma : A Risky Venture ?
The legacy of Viagra, and its creator copyright, presents a complex case study for investors. At first a blockbuster drug, yielding billions in income, its exclusivity period created a wave of generic competition , significantly diminishing its market share . While some firms may try to capitalize on related treatments , the existing landscape dema